SM
TAK icon

SG3 Management’s Takeda Pharmaceutical TAK Stock Holding History

SG3 Management’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-72,500
Closed -$988K – 1353
2021
Q4 		$988K Hold
72,500
– – 0.02% 486
2021
Q3 		$1.19M Hold
72,500
– – 0.04% 424
2021
Q2 		$1.22M Hold
72,500
– – 0.04% 424
2021
Q1 		$1.32M Buy
72,500
+67,500
+1,350% +$1.21M 0.03% 523
2020
Q4 		$91K Hold
5,000
– – ﹤0.01% 936
2020
Q3 		$89K Hold
5,000
– – ﹤0.01% 800
2020
Q2 		$90K Buy
+5,000
New +$89.8K 0.01% 541

Other funds holding TAK

PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return